Literature DB >> 21623644

The influenza pandemic of 2009: lessons and implications.

Paul Shapshak1, Francesco Chiappelli, Charurut Somboonwit, John Sinnott.   

Abstract

Influenza is a moving target, which evolves in unexpected directions and is recurrent annually. The 2009 influenza A/H1N1 pandemic virus was unlike the 2009 seasonal virus strains and originated in pigs prior to infecting humans. Three strains of viruses gave rise to the pandemic virus by antigenic shift, reassortment, and recombination, which occurred in pigs as 'mixing vessels'. The three strains of viruses had originally been derived from birds, pigs, and humans. The influenza hemagglutinin (HA) and neuraminidase (NA) external proteins are used to categorize and group influenza viruses. The internal proteins (PB1, PB1-F2, PB2, PA, NP, M, and NS) are involved in the pathogenesis of influenza infection. A major difference between the 1918 and 2009 pandemic viruses is the lack of the pathogenic protein PB1-F2 in the 2009 pandemic strains, which was present in the more virulent 1918 pandemic strains. We provide an overview of influenza infection since 1847 and the advent of influenza vaccination since 1944. Vaccines and chemotherapy help reduce the spread of influenza, reduce morbidity and mortality, and are utilized by the global rapid-response organizations associated with the WHO. Immediate identification of impending epidemic and pandemic strains, as well as sustained vigilance and collaboration, demonstrate continued success in combating influenza.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623644     DOI: 10.1007/BF03256397

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  146 in total

1.  Ecological and immunological determinants of influenza evolution.

Authors:  Neil M Ferguson; Alison P Galvani; Robin M Bush
Journal:  Nature       Date:  2003-03-27       Impact factor: 49.962

2.  Influenza vaccine--safe, effective, and mistrusted.

Authors:  Katherine M Harris; Jürgen Maurer; Arthur L Kellermann
Journal:  N Engl J Med       Date:  2010-11-24       Impact factor: 91.245

Review 3.  An overview of the epidemiology of avian influenza.

Authors:  Dennis J Alexander
Journal:  Vaccine       Date:  2006-11-09       Impact factor: 3.641

4.  The influenza virus resource at the National Center for Biotechnology Information.

Authors:  Yiming Bao; Pavel Bolotov; Dmitry Dernovoy; Boris Kiryutin; Leonid Zaslavsky; Tatiana Tatusova; Jim Ostell; David Lipman
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

5.  A primer on strategies for prevention and control of seasonal and pandemic influenza.

Authors:  Scott Santibañez; Anthony E Fiore; Toby L Merlin; Stephen Redd
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

6.  Continued evolution of H1N1 and H3N2 influenza viruses in pigs in Italy.

Authors:  L Campitelli; I Donatelli; E Foni; M R Castrucci; C Fabiani; Y Kawaoka; S Krauss; R G Webster
Journal:  Virology       Date:  1997-06-09       Impact factor: 3.616

7.  The Contribution of the PB1-F2 Protein to the Fitness of Influenza A Viruses and its Recent Evolution in the 2009 Influenza A (H1N1) Pandemic Virus.

Authors:  Vladimir Trifonov; Vincent Racaniello; Raul Rabadan
Journal:  PLoS Curr       Date:  2009-08-21

Review 8.  Influenza A virus PB1-F2: a small protein with a big punch.

Authors:  Gina M Conenello; Peter Palese
Journal:  Cell Host Microbe       Date:  2007-10-11       Impact factor: 21.023

Review 9.  Efficacy of whole-cell killed bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic.

Authors:  Yu-Wen Chien; Keith P Klugman; David M Morens
Journal:  J Infect Dis       Date:  2010-10-28       Impact factor: 5.226

10.  Full factorial analysis of mammalian and avian influenza polymerase subunits suggests a role of an efficient polymerase for virus adaptation.

Authors:  Olive T W Li; Michael C W Chan; Cynthia S W Leung; Renee W Y Chan; Yi Guan; John M Nicholls; Leo L M Poon
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

View more
  13 in total

1.  NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors.

Authors:  Nancy Bunin; Trudy Small; Paul Szabolcs; K Scott Baker; Michael A Pulsipher; Troy Torgerson
Journal:  Biol Blood Marrow Transplant       Date:  2011-11-17       Impact factor: 5.742

2.  Genetic characterization of simian foamy viruses infecting humans.

Authors:  Réjane Rua; Edouard Betsem; Sara Calattini; Ali Saib; Antoine Gessain
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

3.  The Impact of the Highly Virulent SARS-CoV-2 Gamma Variant on Young Adults in the State of São Paulo: Was It Inevitable?

Authors:  Beny Spira
Journal:  Cureus       Date:  2022-07-01

Review 4.  Novel vaccine safety issues and areas that would benefit from further research.

Authors:  Daniel A Salmon; Paul Henri Lambert; Hanna M Nohynek; Julianne Gee; Umesh D Parashar; Jacqueline E Tate; Annelies Wilder-Smith; Kenneth Y Hartigan-Go; Peter G Smith; Patrick Louis F Zuber
Journal:  BMJ Glob Health       Date:  2021-05

Review 5.  Universal influenza vaccines, a dream to be realized soon.

Authors:  Han Zhang; Li Wang; Richard W Compans; Bao-Zhong Wang
Journal:  Viruses       Date:  2014-04-29       Impact factor: 5.048

6.  A Conserved Secondary Structural Element in the Coding Region of the Influenza A Virus Nucleoprotein (NP) mRNA Is Important for the Regulation of Viral Proliferation.

Authors:  Marta Soszynska-Jozwiak; Paula Michalak; Walter N Moss; Ryszard Kierzek; Elzbieta Kierzek
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

7.  Research priorities in modeling the transmission risks of H7N9 bird flu.

Authors:  Viroj Wiwanitkit; Benyun Shi; Shang Xia; Guo-Jing Yang; Xiao-Nong Zhou; Jiming Liu
Journal:  Infect Dis Poverty       Date:  2013-08-08       Impact factor: 4.520

8.  Self-Folding of Naked Segment 8 Genomic RNA of Influenza A Virus.

Authors:  Elzbieta Lenartowicz; Julita Kesy; Agnieszka Ruszkowska; Marta Soszynska-Jozwiak; Paula Michalak; Walter N Moss; Douglas H Turner; Ryszard Kierzek; Elzbieta Kierzek
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

9.  Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts.

Authors:  Irina Tutykhina; Ilias Esmagambetov; Alexander Bagaev; Alexey Pichugin; Andrey Lysenko; Dmitry Shcherbinin; Elena Sedova; Denis Logunov; Maxim Shmarov; Ravshan Ataullakhanov; Boris Naroditsky; Alexander Gintsburg
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

Review 10.  Efforts to Improve the Seasonal Influenza Vaccine.

Authors:  Alfred T Harding; Nicholas S Heaton
Journal:  Vaccines (Basel)       Date:  2018-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.